146
Views
0
CrossRef citations to date
0
Altmetric
Think Piece

A social history of opioids’ crimedical cycle

, , , , , , & show all
Received 10 Jun 2023, Accepted 07 Nov 2023, Published online: 02 Dec 2023

References

  • Abrams MH. 1971. The milk of paradise: the effect of opium visions on the works of Dequincey, Crabbe, Francis Thompson, and Coleridge. New York: Octagon Books.
  • Ahmad DL. 2000. Opium smoking, anti‐Chinese attitudes, and the American medical community, 1850–1890. Am Nineteenth Century Hist. 1(2):53–68. doi:10.1080/14664650008567016.
  • Ahmed S, Sarfraz Z, Sarfraz A. 2022. A changing epidemic and the rise of opioid-stimulant co-use. Front Psychiatry. 13:918197. doi:10.3389/fpsyt.2022.918197.
  • Aldrich MR. 1994. Historical notes on women addicts. J Psychoact Drugs. 26(1):61–64. doi:10.1080/02791072.1994.10472602.
  • Aragón-Poce F, Martínez-Fernández E, Marquez-Espinos C, Perez A, Mora R, Torres L. 2002. History of opium. Int Congr Ser. 1242:19–21. doi:10.1016/S0531-5131(02)00600-3.
  • Avicenna H. 1978. Ghanoon Dar Teb [The canon of medicine]. Bulaq ed. Sharafkandi A, translator. Tehran: Univ of Tehran Pr.
  • Azadfard M, Huecker MR, Leaming JM. 2023. Opioid addiction. In: Statpearls. Treasure Island (FL): Statpearls Publishing; https://www.ncbi.nlm.nih.gov/books/NBK448203/.
  • Bartholomew TS, Andraka-Cristou B, Totaram RK, Harris S, Doblecki-Lewis S, Ostrer L, Serota DP, Forrest DW, Chueng TA, Suarez E, et al. 2022. We want everything in a one-stop shop": acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs. Harm Reduct J. 19(1):133. doi:10.1186/s12954-022-00721-6.
  • Baxter HJ, Johnson MH, Bean D. 2012. Efficacy of a character strengths and gratitude intervention for people with chronic back pain. Austr J Rehabil Counsel. 18(2):135–147. doi:10.1017/jrc.2012.14.
  • Becker HS. 1953. Becoming a marihuana user. Am J Soc. 59(3):235–242. doi:10.1086/221326.
  • Beckett K, Brydolf-Horwitz M. 2020. A kinder, gentler drug war? Race, drugs, and punishment in 21st century America. Punish Soc. 22(4):509–533. doi:10.1177/1462474520925145.
  • Bennett AS, Bell A, Tomedi L, Hulsey EG, Kral AH. 2011. Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health. 88(6):1020–1030. doi:10.1007/s11524-011-9600-7.
  • Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. 1998. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Def Syndr Hum Retrovirol. 18(5):505–511. doi:10.1097/00042560-199808150-00013.
  • Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. 2000. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 14(5):605–611. doi:10.1097/00002030-200003310-00015.
  • Brook JS, Whiteman M, Balka EB, Win PT, Gursen MD. 1998. Drug use among Puerto Ricans: ethnic identity as a protective factor. Hispanic Journal of Behavioral Sciences. 20(2):241–254. doi:10.1177/07399863980202007.
  • Brown VB, Harris M, Fallot R. 2013. Moving toward trauma-informed practice in addiction treatment: a collaborative model of agency assessment. J Psychoact Drugs. 45(5):386–393. doi:10.1080/02791072.2013.844381.
  • Cape GS. 2003. Addiction, stigma and movies. Acta Psychiatr Scand. 107(3):163–169. doi:10.1034/j.1600-0447.2003.00075.x.
  • Cochran G, Chen Q, Field C, Seybert AL, Hruschak V, Jaber A, Gordon AJ, Tarter R. 2019. A community pharmacy-led intervention for opioid medication misuse: a small-scale randomized clinical trial. Drug Alcohol Depend. 205:107570. doi:10.1016/j.drugalcdep.2019.107570.
  • Cochran G, Smid MC, Krans EE, Bryan MA, Gordon AJ, Lundahl B, Silipigni J, Haaland B, Tarter R. 2019. A pilot multisite study of patient navigation for pregnant women with opioid use disorder. Contemp Clin Trials. 87:105888. doi:10.1016/j.cct.2019.105888.
  • Collins AB, Boyd J, Cooper HLF, McNeil R. 2019. The intersectional risk environment of people who use drugs. Soc Sci Med. 234:112384. doi:10.1016/j.socscimed.2019.112384.
  • Courtwright DT. 1978. Opiate addiction as a consequence of the Civil War. Civil War Hist. 24(2):101–111. doi:10.1353/cwh.1978.0039.
  • Croll PR, Gerteis J. 2019. Race as an open field: exploring identity beyond fixed choices. Soc Race Ethn. 5(1):55–69. doi:10.1177/2332649217748425.
  • Dannerbeck A, Harris G, Sundet P, Lloyd K. 2006. Understanding and responding to racial differences in drug court outcomes. J Ethn Subst Abuse. 5(2):1–22. doi:10.1300/J233v05n02_01.
  • Day E, Wall R, Chohan G, Seddon J. 2015. Perceptions of professional drug treatment staff in England about client barriers to narcotics anonymous attendance. Addiction Res Theory. 23(3):223–230. doi:10.3109/16066359.2014.976205.
  • Denham BE. 2010. Amplifications of deviance surrounding illicit drug use: conceptualizing a role for film. Commun Cult Crit. 3(4):485–502. doi:10.1111/j.1753-9137.2010.01082.x.
  • Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. 2009. Doing harm reduction better: syringe exchange in the United States. Addiction. 104(9):1441–1446. doi:10.1111/j.1360-0443.2008.02465.x.
  • Dishion TJ, McCord J, Poulin F. 1999. When interventions harm: peer groups and problem behavior. Am Psychol. 54(9):755–764. doi:10.1037/0003-066X.54.9.755.
  • Duterte M, Hemphill K, Murphy T, Murphy S. 2003. Tragic beauties: heroin images and heroin users. Contemp Drug Prob. 30(3):595–617. doi:10.1177/009145090303000304.
  • Engen RL, Steen S. 2000. The power to punish: discretion and sentencing reform in the war on drugs. Am J Soc. 105(5):1357–1395. http://www.jstor.org/stable/3003769. doi:10.1086/210433.
  • Farooqui A. 2005. Smuggling as subversion: colonialism, indian merchants, and the politics of opium, 1790–1843. Lanham (MD): Lexington Books.
  • Fatkin T, Moore SK, Okst K, Creedon T, Samawi F, Fredericksen AK, Roll D, Oxnard A, Cook B, Schuman-Olivier Z. 2021. Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): a concurrent mixed methods study. J Subst Abuse Treat. 130:108415. doi:10.1016/j.jsat.2021.108415.
  • Faulkner-Gurstein R. 2017. The social logic of naloxone: peer administration, harm reduction, and the transformation of social policy. Soc Sci Med. 180:20–27. doi:10.1016/j.socscimed.2017.03.013.
  • Fitzgerald JL, Louie R, Rosenthal D, Crofts N. 1999. The meaning of the rush for initiates to injecting drug use. Contemp Drug Prob. 26(3):481–504. doi:10.1177/009145099902600307.
  • Gray M. 2011. Back to basics: a critique of the strengths perspective in social work. Fam Soc. 92(1):5–11. doi:10.1606/1044-3894.4054.
  • Graziosi M, Yaden DB, Clifton JDW, Mikanik N, Niemiec RM. 2020. A strengths-based approach to chronic pain. J Posit Psychol. 17(3):400–408. doi:10.1080/17439760.2020.1858337.
  • Guo X, Slesnick N. 2017. Reductions in hard drug use among homeless youth receiving a strength-based outreach intervention: comparing the long-term effects of shelter linkage versus drop-in center linkage. Subst Use Misuse. 52(7):905–915. Academic Search Premier. doi:10.1080/10826084.2016.1267219.
  • Hanes WT, Sanello F. 2002. The opium wars: the addiction of one empire and the corruption of another. Naperville (IL): Sourcebooks, Inc.
  • Hanson BL, Porter RR, Zöld AL, Terhorst-Miller H. 2020. Preventing opioid overdose with peer-administered naloxone: findings from a rural state. Harm Reduct J. 17(1):1–9. doi:10.1186/s12954-019-0352-0.
  • Havens JR, Cornelius LJ, Ricketts EP, Latkin CA, Bishai D, Lloyd JJ, Huettner S, Strathdee SA. 2007. The effect of a case management intervention on drug treatment entry among treatment-seeking injection drug users with and without comorbid antisocial personality disorder. J Urban Health. 84(2):267–271. doi:10.1007/s11524-006-9144-4.
  • Hatzenbuehler ML. 2016. Structural stigma: research evidence and implications for psychological science. Am Psychol. 71(8):742–751. doi:10.1037/amp0000068.
  • Hayter A. 1968. Opium and the romantic imagination. Berkeley: University of California Press.
  • Hedges KE. 2012. A family affair: contextual accounts from addicted youth growing up in substance using families. J Youth Stud. 15(3):257–272. doi:10.1080/13676261.2011.635194.
  • Hickman TA. 2000. Drugs and race in American culture: orientalism in the turn-of-the-century discourse of narcotic addiction. Am Stud. 41(1):71–91.
  • Higgs P, Owada K, Hellard M, Power R, Maher L. 2008. Gender, culture and harm: an exploratory study of female heroin users of Vietnamese ethnicity. Cult Health Sex. 10(7):681–695. doi:10.1080/13691050802203838.
  • Hosztafi S. 2001. The history of heroin. Acta Pharm Hung. 71(2):233–242.
  • Howard D. 2016. Race, neighborhood, and drug court graduation. Just Q. 33(1):159–184. doi:10.1080/07418825.2014.908938.
  • Hughes K. 2007. Migrating identities: the relational constitution of drug use and addiction. Sociol Health Illn. 29(5):673–691. doi:10.1111/j.1467-9566.2007.01018.x.
  • Jacka BP, Goldman JE, Yedinak JL, Bernstein E, Hadland SE, Buxton JA, Sherman SG, Biello KB, Marshall BD. 2020. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: Study protocol for a randomized controlled trial. Trials. 21(1):1–10. doi:10.1186/s13063-020-04898-8.
  • Janin H. 1999. The India-China opium trade in the nineteenth century. Jefferson (NC): McFarland.
  • Johnston G. 2020. The kids are all white: examining race and representation in news media coverage of opioid overdose deaths in Canada. Sociol Inq. 90(1):123–146. doi:10.1111/soin.12269.
  • Kang H, Zhang P, Lee S, Shen S, Dunham E. 2022. Racial disparities in opioid administration and prescribing in the emergency department for pain. Am J Emerg Med. 55:167–173. doi:10.1016/j.ajem.2022.02.043.
  • Kim K, Oh H, Miller D, Veloso D, Lin J, McFarland W. 2021. Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: naloxone training among injectors in San Francisco. Int J Drug Pol. 90:102778. doi:10.1016/j.drugpo.2020.102778.
  • Kolla G, Strike C. 2020. Medicalization under prohibition: the tactics and limits of medicalization in the spaces where people use illicit drugs. Drugs Educ Prev Pol. 28(2):127–137. doi:10.1080/09687637.2020.1769029.
  • Kral AH, Lambdin BH, Comfort M, Powers C, Cheng H, Lopez AM, Murdoch RO, Neilands TB, Lorvick J. 2018. A strengths-based case management intervention to reduce HIV viral load among people who use drugs. AIDS Behav. 22(1):146–153. doi:10.1007/s10461-017-1903-6.
  • Kral AH, Lambdin BH, Wenger LD, Davidson PJ. 2020. Evaluation of an unsanctioned safe consumption site in the United States. N Engl J Med. 383(6):589–590. doi:10.1056/NEJMc2015435.
  • Krikorian AD. 1975. Were the opium poppy and opium known in the ancient Near East? J Hist Biol. 8(1):95–114.
  • Kubiak S, Covington S, Hillier C. 2017. Trauma-informed corrections. Soc Work Juvenile Crim Just Syst. 4:92–104.
  • Kurtz SP, Pagano ME, Buttram ME, Ungar M. 2019. Brief interventions for young adults who use drugs: the moderating effects of resilience and trauma. J Subst Abuse Treat. 101:18–24. doi:10.1016/j.jsat.2019.03.009.
  • Lambdin BH, Davidson PJ, Browne EN, Suen LW, Wenger LD, Kral AH. 2022. Reduced emergency department visits and hospitalisation with use of an unsanctioned safe consumption site for injection drug use in the United States. J Gen Intern Med. 37(15):3853–3860. doi:10.1007/s11606-021-07312-4.
  • Larsen DJ, King RL, Stege R, Egeli NA. 2015. Hope in a strengths-based group activity for individuals with chronic pain. Counsel Psychol Q. 28(2):175–199. doi:10.1080/09515070.2015.1007444.
  • Lassiter MD. 2015. Impossible criminals: the suburban imperatives of America’s war on drugs. J Am Hist. 102(1):126–140. doi:10.1093/jahist/jav243.
  • Lavie-Ajayi M, Ziv A, Pinson H, Ram H, Avieli N, Zur E, Tzur E, Nimrod G. 2022. Recreational cannabis use and identity formation: a collective memory work study. World Leisure J. 64(4):325–341. doi:10.1080/16078055.2022.2043428.
  • Lenton SR, Dietze PM, Degenhardt L, Darke S, Butler TG. 2009. Naloxone for administration by peers in cases of heroin overdose. Med J Aust. 191(8):469–469. doi:10.5694/j.1326-5377.2009.tb02891.x.
  • Levy S, Campbell MD, Shea CL, DuPont R. 2018. Trends in abstaining from substance use in adolescents: 1975–2014. Pediatrics. 142(2). doi:10.1542/peds.2017-3498.
  • Linas BP, Savinkina A, Barbosa C, Mueller PP, Cerdá M, Keyes K, Chhatwal J. 2021. A clash of epidemics: impact of the COVID-19 pandemic response on opioid overdose. J Subst Abuse Treat. 120:108158. doi:10.1016/j.jsat.2020.108158.
  • Link BG, Phelan J. 1995. Social conditions as fundamental causes of disease. J Health Soc Behav. 35:80–80. doi:10.2307/2626958.
  • Liu SH. 2011. A precarious rite of passage in postreform China: heroin use among Nuosu youths on the move. Med Anthropol Q. 25(3):395–411. doi:10.1111/j.1548-1387.2011.01168.x.
  • Longshore D, Turner S, Wenzel S, Morral A, Harrell A, McBride D, Deschenes E, Iguchi M. 2001. Drug courts: a conceptual framework. J Drug Issues. 31(1):7–25. doi:10.1177/002204260103100103.
  • López‐Castro T, Hu M, Papini S, Ruglass LM, Hien DA. 2015. Pathways to change: use trajectories following trauma‐informed treatment of women with co‐occurring post‐traumatic stress disorder and substance use disorders. Drug Alcohol Rev. 34(3):242–251. doi:10.1111/dar.12230.
  • Lunze K, Kiriazova T, Blokhina E, Bushara N, Bridden C, Gnatienko N, Bendiks S, Quinn E, Krupitsky E, Raj A, et al. 2020. Linking HIV-positive people in addiction care to HIV services in St. Petersburg, Russia – mixed-methods implementation study of strengths-based case management. Global Publ Heal. 16(11):1711–1723. doi:10.1080/17441692.2020.1834599.
  • Macht DI. 1915. The history of opium and some of its preparations and alkaloids. JAMA. LXIV(6):477–481. doi:10.1001/jama.1915.02570320001001.
  • Maclin-Akinyemi C, Thurston IB, Howell KH, Jamison LE, Anderson MB. 2019. The protective roles of ethnic identity and community cohesion on substance use among Black women experiencing adversity. J Ethn Subst Abuse. 20(2):225–240. doi:10.1080/15332640.2019.1622477.
  • Marcellus L. 2014. Supporting women with substance use issues: trauma-informed care as a foundation for practice in the NICU. Neonatal Netw. 33(6):307–314. doi:10.1891/0730-0832.33.6.307.
  • Marlowe DB, Festinger DS, Dugosh KL, Benasutti KM, Fox G, Harron A. 2014. An experimental trial of adaptive programming in drug court: outcomes at 6, 12 and 18 months. J Exp Criminol. 10(2):129–149. doi:10.1007/s11292-013-9196-x.
  • Marshall C, Piat M, Perreault M. 2018. Exploring the psychological benefits and challenges experienced by peer-helpers participating in take-home naloxone programmes: a rapid review. Drugs Educ Prev Pol. 25(3):280–291. doi:10.1080/09687637.2016.1269724.
  • Matsuguma S, Kawashima M, Uchino M, Tsubota K. 2018. Value of considering psychological strengths in patients with eye pain. Am J Ophthal Case Rep. 12:91–92. doi:10.1016/j.ajoc.2018.10.003.
  • McDonagh J, Wickes B. 2020. The nineteenth-century opium complex: from Thomas Love Peacock to Sherlock Holmes. Lit Hist. 29(1):3–18. doi:10.1177/0306197320907437.
  • McGinty EE, Kennedy-Hendricks A, Barry CL. 2019. Stigma of addiction in the media. In: The stigma of addiction. New York: Springer. p. 201–214.
  • McNamara JD. 1973. The history of United States anti-opium policy. Fed Probat. 37:15.
  • Mercer F, Miler JA, Pauly B, Carver H, Hnízdilová K, Foster R, Parkes T. 2021. Peer support and overdose prevention responses: a systematic ‘state-of-the-art’ review. IJERPH. 18(22):12073. doi:10.3390/ijerph182212073.
  • Merrick MT, Ford DC, Haegerich TM, Simon T. 2020. Adverse childhood experiences increase risk for prescription opioid misuse. J Primary Prevent. 41(2):139–152. doi:10.1007/s10935-020-00578-0.
  • Morgan AA, Thomas ME, Brossoie N. 2020. Trauma-informed care (TIC) as a framework for addressing the opioid epidemic in Appalachia: an exploratory interpretative phenomenological analysis. J Rural Ment Heal. 44(3):156–169. doi:10.1037/rmh0000137.
  • Mueller C. 2019. Adolescent understandings of disability labels and social stigma in school. Int J Qual Stud Educ. 32(3):263–281. doi:10.1080/09518398.2019.1576940.
  • Muncan B, Walters SM, Ezell J, Ompad DC. 2020. “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J. 17(1):53. doi:10.1186/s12954-020-00399-8.
  • Musto DF. 1987. The history of legislative control over opium, cocaine, and their derivatives. In: Dealing with drugs: consequences of government control. Lexington: Lexington Books.
  • Musto DF. 1991. Opium, cocaine and marijuana in American history. Sci Am. 265(1):40–47. doi:10.1038/scientificamerican0791-40.
  • Nelson M, Lenton S, Dietze P, Olsen A, Agramunt S. 2016. Evaluation of the WA peer naloxone project–final report. Perth (Australia): National Drug Research Institute, Curtin University.
  • Netherland J, Hansen HB. 2016. The war on drugs that wasn’t: wasted whiteness,“dirty doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 40(4):664–686. doi:10.1007/s11013-016-9496-5.
  • Niles JK, Gudin J, Radcliff J, Kaufman HW. 2021. The opioid epidemic within the COVID-19 pandemic: drug testing in 2020. Popul Heal Manag. 24(S1):S-43–S-51. doi:10.1089/pop.2020.0230.
  • Oetting ER, Donnermeyer JF. 1998. Primary socialization theory: the etiology of drug use and deviance. I. Subst Use Misuse. 33(4):995–1026. PMID: 9548633. doi:10.3109/10826089809056252.
  • Oh H, Kim K, Miller D, Veloso D, Lin J, McFarland W. 2020. Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco. Int J Drug Pol. 82:102787. doi:10.1016/j.drugpo.2020.102787.
  • Olding M, Boyd J, Kerr T, McNeil R. 2021. “And we just have to keep going”: task shifting and the production of burnout among overdose response workers with lived experience. Soc Sci Med. 270:113631. doi:10.1016/j.socscimed.2020.113631.
  • Pearson G. 2001. Normal drug use: ethnographic fieldwork among an adult network of recreational drug users in inner London. Subst Use Misuse. 36(1–2):167–200. doi:10.1081/JA-100000234.
  • Phillips A. 2012. Saving civilization from empire: belligerency, pacifism and the two faces of civilization during the Second Opium War. Eur J Int Relat. 18(1):5–27. doi:10.1177/1354066111416020.
  • Phinney JS, Ong AD. 2007. Conceptualization and measurement of ethnic identity: current status and future directions. J Counsel Psychol. 54(3):271–281. doi:10.1037/0022-0167.54.3.271.
  • Provine DM. 2011. Race and inequality in the war on drugs. Annu Rev Law Soc Sci. 7(1):41–60. doi:10.1146/annurev-lawsocsci-102510-105445.
  • Quinones MA. 1975. Drug abuse during the Civil War (1861–1865). Int J Addict. 10(6):1007–1020. doi:10.3109/10826087509028357.
  • Rambachan A, Fang MC, Prasad P, Iverson N. 2021. Racial and ethnic disparities in discharge opioid prescribing from a hospital medicine service. J Hosp Med. 16(10):589–595. doi:10.12788/jhm.3667.
  • Rapp RC, Kelliher CW, Fisher JH, Hall FJ. 1994. Strengths-based case management. A role in addressing denial in substance abuse treatment. J Case Manage. 3(4):139–144.
  • Redko C, Rapp RC, Elms C, Snyder M, Carlson RG. 2007. Understanding the working alliance between persons with substance abuse problems and strengths-based case managers. J Psychoact Drugs. 39(3):241–250. doi:10.1080/02791072.2007.10400610.
  • Regis A, Meyers-Ohki SE, Mennenga SE, Greco PP, Glisker R, Kolaric R, McCormack RP, Rapp RC, Bogenschutz MP. 2020. Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial. Trials. 21(1):1–14. doi:10.1186/s13063-020-04684-6.
  • Revier K. 2021. “Without drug court, you’ll end up in prison or dead”: therapeutic surveillance and addiction narratives in treatment court. Crit Crim. 29(4):915–930. doi:10.1007/s10612-021-09592-y.
  • Romanelli RJ, Shen Z, Szwerinski N, Scott A, Lockhart S, Pressman AR. 2019. Racial and ethnic disparities in opioid prescribing for long bone fractures at discharge from the emergency department: a cross-sectional analysis of 22 centers from a health care delivery system in Northern California. Ann Emerg Med. 74(5):622–631. doi:10.1016/j.annemergmed.2019.05.018.
  • Roll JM, Prendergast M, Richardson K, Burdon W, Ramirez A. 2005. Identifying predictors of treatment outcome in a drug court program. Am J Drug Alcohol Abuse. 31(4):641–656. doi:10.1081/ADA-200068428.
  • Roth AM, Mitchell AK, Mukherjee R, Scheim AI, Ward KM, Lankenau SE. 2021. Prevalence and correlates of syringe disposal box use in a Philadelphia neighborhood with high levels of public drug injection. Subst Use Misuse. 56(5):668–673. doi:10.1080/10826084.2021.1887252.
  • Saleebey D. 1996. The strengths perspective in social work practice: extensions and cautions. Soc Work. 41(3):296–305.
  • Samet JH, Blokhina E, Cheng DM, Walley AY, Lioznov D, Gnatienko N, Quinn EK, Bridden C, Chaisson CE, Toussova O, et al. 2019. A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV care. AIDS (London, England). 33(9):1467–1476.)doi:10.1097/QAD.0000000000002230.
  • Shearer D, Fleming T, Fowler A, Boyd J, McNeil R. 2019. Naloxone distribution, trauma, and supporting community-based overdose responders. Int J Drug Policy. 74:255–256. doi:10.1016/j.drugpo.2018.11.008.
  • Singh GK, Kim IE, Girmay M, Perry C, Daus GP, Vedamuthu IP, De Los Reyes AA, Ramey CT, Martin EK, Allender M. 2019. Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns. Int J MCH AIDS. 8(2):89–100. doi:10.21106/ijma.284.
  • Sperlich MI, Bascug EW, Green SA, Koury S, Hales T, Nochajski TH. 2021. Trauma-informed parenting education support groups for mothers in substance abuse recovery. Res Soc Work Pract. 31(7):742–757. doi:10.1177/10497315211007568.
  • Stevens-Watkins D, Perry B, Harp KL, Oser CB. 2012. Racism and illicit drug use among African American women: The protective effects of ethnic identity, affirmation, and behavior. J Black Psychol. 38(4):471–496. doi:10.1177/0095798412438395.
  • Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. 2020. Opioid use disorder. Nat Rev Dis Primers. 6(1):3. doi:10.1038/s41572-019-0137-5.
  • Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, Havens JR, Beilenson P, Rapp C, Lloyd JJ, Latkin CA. 2006. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend. 83(3):225–232. doi:10.1016/j.drugalcdep.2005.11.015.
  • Taplin C, Saddichha S, Li K, Krausz MR. 2014. Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection. Subst Use Misuse. 49(10):1311–1316. doi:10.3109/10826084.2014.901383.
  • Trocki C. 2012. Opium, empire and the global political economy: a study of the Asian opium trade 1750-1950. New York: Routledge.
  • Vederhus JK, Høie M, Birkeland B. 2020. One size doesn’t fit all: a thematic analysis of interviews with people who have stopped participating in Narcotics Anonymous in Norway. Addict Sci Clin Pract. 15(1):18. doi:10.1186/s13722-020-00191-w.
  • Weegmann M. 2021. Mapping addiction, describing trauma, building hope. In: Using image and narrative in therapy for trauma, addiction and recovery. 246. London, England: Jessica Kingsley.
  • Westermeyer J. 1976. The pro-heroin effects of anti-opium laws in Asia. Arch Gen Psychiatry. 33(9):1135–1139. doi:10.1001/archpsyc.1976.01770090125014.
  • Wheeler E, Jones TS, Gilbert MK, Davidson PJ, Centers for Disease Control and Prevention (CDC). 2015. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 64(23):631–635.
  • Windle J. 2013. How the east influenced drug prohibition. Int Hist Rev. 35(5):1185–1199. doi:10.1080/07075332.2013.820769.
  • Wood E, Elliott M. 2020. Opioid addiction stigma: the intersection of race, social class, and gender. Subst Use Misuse. 55(5):818–827. doi:10.1080/10826084.2019.1703750.
  • Yang YT, Beletsky L. 2020. United States vs Safehouse: the implications of the Philadelphia supervised consumption facility ruling for law and social stigma. Prev Med. 135:106070. doi:10.1016/j.ypmed.2020.106070.
  • Zoccatelli G. 2014. “It was fun, it was dangerous”: heroin, young urbanities and opening reforms in China’s borderlands. Int J Drug Pol. 25(4):762–768. doi:10.1016/j.drugpo.2014.06.004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.